Infectious disease
HIV-1 p17 Gag 77-85 (HLA-A*02:01) SLYNTVATL
Product number: EP07855_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
SLYNTVATL is a linear peptidic epitope (epitope ID59613) studied as part of Gag polyprotein from Human immunodeficiency virus 1 and Gag-Pol polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays. HIV gag peptide SLYNTVATL (HLA-A*02:01) for stimulation of T-cells. Single peptide HIV-1 p17 Gag 77-85 (HLA-A*02:01) SLYNTVATL for stimulation of human HIV gag-specific CD8+ T-cells.
TechData
| Sequence: | SLYNTVATL |
| Gene: | gag-pol |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Gag-Pol polyprotein |
| Species: | Human immunodeficiency virus 1 (HIV-1) |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |